Physician profile
Michael A Levine
NPI 1750388146
$7,658.53
in general payments reported to CMS, 2019-2025
39 companies · $1,663 in 2025
The $1,663 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,130 · 2020: $801 · 2021: $663 · 2022: $864 · 2023: $1,238 · 2024: $1,299 · 2025: $1,663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,200.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,225.58 | 2019-2025 | Erleada, Akeega, Carvykti |
| Astellas Pharma US INC | $947.38 | 2019-2024 | Xtandi, Myrbetriq |
| Boston Scientific Corporation | $624.95 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $504.42 | 2023-2025 | Gemtesa, Orgovyx |
| Valencia Technologies Corporation | $457.99 | 2025 | Ecoin Device Kit |
| Ferring Pharmaceuticals INC. | $409.53 | 2019-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $349.93 | 2022-2025 | |
| Edap Technomed INC | $300.00 | 2023 | |
| Teleflex LLC | $252.87 | 2021-2025 | Urolift |
| Urogen Pharma, INC. | $248.41 | 2022-2025 | Jelmyto |
| Myovant Sciences INC. | $177.67 | 2021-2022 | |
| Procept Biorobotics Corporation | $174.52 | 2023 | Aquabeam Robotic System |
| Neotract INC. | $171.62 | 2019-2020 | |
| Urovant Sciences INC | $167.48 | 2021-2022 | |
| Pfizer INC. | $150.83 | 2019-2025 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Srs Medical Systems, INC. | $148.63 | 2024 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Dendreon Pharmaceuticals LLC | $127.49 | 2019-2025 | Provenge |
| Astrazeneca Pharmaceuticals Lp | $125.00 | 2024 | Lynparza |
| Janssen Pharmaceuticals, INC | $124.99 | 2024 | Xarelto |
| Progenics Pharmaceuticals, INC. | $124.34 | 2023 | Pylarify |
| Alexion Pharmaceuticals, INC. | $116.68 | 2024 | |
| Tolmar, INC. | $84.44 | 2023-2025 | Jatenzo |
| Profound Medical Corp. | $83.09 | 2025 | Tulsa-Pro |
| Olympus America INC. | $82.23 | 2022-2025 | Itind System |
| Amgen INC. | $70.18 | 2019-2021 | |
| Abbvie INC. | $49.04 | 2020-2024 | |
| Endo Pharmaceuticals INC. | $48.70 | 2019-2020 | |
| Eisai INC. | $41.15 | 2019 | |
| Myriad Genetic Laboratories, INC. | $39.98 | 2025 | Prolaris |
| Sun Pharmaceutical Industries INC. | $33.07 | 2022-2025 | |
| Scpharmaceuticals INC. | $29.43 | 2024 | |
| Civco Medical Instruments | $29.04 | 2025 | |
| Eagle Pharmaceuticals, INC. | $24.98 | 2023 | |
| Blue Earth Diagnostics | $24.96 | 2020 | |
| Calyxo, INC. | $20.03 | 2025 | Cvac Aspiration System |
| Coloplast Corp | $19.57 | 2022 | |
| Allergan, INC. | $17.70 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $15.80 | 2021 | |
| Axonics, INC. | $14.83 | 2024 | Bulkamid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.